Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
302.50    0.50 (0.17%)
Bid:
302.50
Ask:
303.00
Spread: 0.50 (0.165%)
Market Cap: £178.58m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Trading Update

2 Oct 2018 07:00

RNS Number : 6100C
Treatt PLC
02 October 2018
 

2 October 2018

 

TREATT PLC

 

Trading update for year ended 30 September 2018

 

Treatt Plc ('Treatt' or the 'Group'), the manufacturer and supplier of innovative ingredient solutions for the flavour, fragrance, beverage and consumer product industries today publishes a trading update for the year ended 30 September 2018.

 

The Board is pleased to confirm that the Group has performed well in the second half of the financial year and despite some foreign exchange headwinds expects to report profit before tax and exceptional items for the year ended 30 September 2018 in line with the Board's earlier expectations.

 

In the 2018 financial year the Group made significant strategic progress in securing funding for its capital investment programmes in the UK and US through an equity fund raising, and the disposal of its non-core business Earthoil Plantations.

 

The $14m US expansion is progressing well, on time and on budget with building work at an advanced stage and is expected to be fully operational during H1 2019. This will provide much-needed additional manufacturing capacity as well as enhancing the Group's scientific capabilities in the US. Plans for the relocation of the Group's UK site are progressing well. The site will be a purpose-built science-led facility designed to drive growth with domestic and international fast-moving consumer goods companies as well as creating a scalable business for the long term. We are at the advanced stages of assessing the design options for the facilities we need in order to deliver the best possible value for shareholders.

 

Meanwhile, following the exceptionally strong year in 2017, the Group has continued to grow over the last year with revenue on a like-for-like basis (excluding Earthoil) expected to be up by approximately 9%. All product categories have grown over the past twelve months, with the key growth drivers of citrus, tea and sugar reduction continuing to deliver. The combined impact of foreign exchange movements, fluctuations in raw material prices and some pricing pressure on new business wins has resulted in gross margins falling a little compared with the prior year.

 

Following the cash inflows from the equity fund raise and disposal of Earthoil, the Group is expected to end the year with a net cash balance of £9m-£10m and an increase in working capital of more than £10m compared with the prior year, most of which relates to an increase in accounts receivable, inventory and some amounts receivable in relation to the disposal of Earthoil. The increase in accounts receivable was partly as a consequence of timing issues and partly related to longer payment terms with a number of larger multi-national customers.

 

Looking ahead, last year the Board approved a strategic plan to drive the business through to 2022. As we enter a key investment phase for the Group, both in terms of our operating capabilities and our people, the Board looks forward to the year ahead and beyond with confidence.

 

Treatt's results for the year ended 30 September 2018 will be announced on 27 November 2018. 

Enquiries:

 

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Bank Plc

Patrick Robb +44 (0)20 7597 5970

David Anderson

Alex Wright

 

Public relations

DRD Partnership

Lawrence Dore +44 (0)20 3951 0349

 

 

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international foot print enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

For further information about the Group, visit www.treatt.com.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFVDIILLIIT
Date   Source Headline
18th Mar 20154:59 pmRNSDirector/PDMR Shareholding
11th Feb 20154:19 pmRNSUpdate on Earthoil Earn-out Dispute
30th Jan 20154:09 pmRNSResult of AGM
14th Jan 20153:42 pmRNSDirector/PDMR Shareholding
8th Jan 201510:18 amRNSDirector/PDMR Shareholding
5th Jan 20153:26 pmRNSReplacement Director/PDMR Shareholding
5th Jan 201511:30 amRNSDirector/PDMR Shareholding
31st Dec 20147:00 amRNSAnnual Information Update
31st Dec 20147:00 amRNSTotal Voting Rights
16th Dec 20145:02 pmRNSDirector/PDMR Shareholding
12th Dec 20143:56 pmRNSAnnual Financial Report
9th Dec 20147:00 amRNSFinal Results
2nd Dec 20147:00 amRNSBlock Listing Application
28th Oct 20143:00 pmRNSVoting Rights and Capital
23rd Oct 20142:38 pmRNSDirector/PDMR Shareholding
7th Oct 20144:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20141:50 pmRNSDirector/PDMR Shareholding
1st Oct 20147:00 amRNSTrading Statement
30th Sep 20144:02 pmRNSTotal Voting Rights
29th Sep 20144:25 pmRNSDirector/PDMR Shareholding
1st Sep 20149:22 amRNSDirector/PDMR Shareholding
29th Aug 20147:00 amRNSTotal Voting Rights
1st Aug 20142:25 pmRNSDirector/PDMR Shareholding
29th Jul 201410:03 amRNSDirector/PDMR Shareholding
29th Jul 20147:00 amRNSInterim Management Statement
1st Jul 20143:44 pmRNSDirector/PDMR Shareholding
1st Jul 20148:32 amRNSDirector/PDMR Shareholding
30th Jun 20143:17 pmRNSHolding(s) in Company
23rd May 20144:39 pmRNSHolding(s) in Company
20th May 20147:00 amRNSHalf Year Results
19th May 20149:47 amRNSVoting Rights and Capital
16th May 201412:07 pmRNSResult of EGM
16th Apr 20141:41 pmRNSNotice of EGM
9th Apr 20142:34 pmRNSDirector/PDMR Shareholding
7th Apr 201410:56 amRNSNotice of EGM
24th Feb 20145:12 pmRNSResult of AGM
10th Feb 20147:00 amRNSInterim Management Statement
31st Dec 20137:00 amRNSAnnual Information Update
23rd Dec 20134:35 pmRNSDirector/PDMR Shareholding
19th Dec 201310:32 amRNSAnnual Financial Report
13th Dec 20139:48 amRNSDirector/PDMR Shareholding
9th Dec 20137:00 amRNSFinal Results
22nd Oct 20134:22 pmRNSDirector/PDMR Shareholding
17th Oct 20132:53 pmRNSDirector/PDMR Shareholding
30th Sep 201312:54 pmRNSVoting Rights and Capital
30th Sep 20137:00 amRNSTrading Statement
26th Sep 20133:17 pmRNSDirector/PDMR Shareholding
13th Sep 201310:54 amRNSHolding(s) in Company
3rd Sep 20139:23 amRNSDirector/PDMR Shareholding
1st Aug 20137:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.